Experts warn of continued IV fluid shortage as gray market manufacturers engage in price gouging. Baxter restarts some production after Hurricane Helene.
Baxter International cut its annual profit forecast on Friday, citing hurricane-related disruptions at its North Carolina intravenous solutions facility, causing its shares to fall 1.3% in premarket ...
The Food and Drug Administration approved changing the expiration date on multiple types of intravenous and sterile ... There was a shortage of some IV-fluid products in the U.S. before Hurricane ...